These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 22575314)
1. Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease. Barbato E; Bartunek J; Mangiacapra F; Sciarretta S; Stanzione R; Delrue L; Cotugno M; Marchitti S; Iaccarino G; Sirico G; Di Castro S; Evangelista A; Lambrechts D; Sinnaeve P; De Bruyne B; Van De Werf F; Janssens S; Fox KA; Wijns W; Volpe M; Rubattu S J Am Coll Cardiol; 2012 May; 59(20):1763-70. PubMed ID: 22575314 [TBL] [Abstract][Full Text] [Related]
2. Association between the atrial natriuretic peptide rs5065 gene polymorphism and the presence and severity of coronary artery disease in an Iranian population. Ziaee S; Kalayinia S; Boroumand MA; Pourgholi L; Cheraghi S; Anvari MS; Sheikhvatan M Coron Artery Dis; 2014 May; 25(3):242-6. PubMed ID: 24487939 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients. Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551 [TBL] [Abstract][Full Text] [Related]
4. Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease. von Haehling S; Papassotiriou J; Hartmann O; Doehner W; Stellos K; Geisler T; Wurster T; Schuster A; Botnar RM; Gawaz M; Bigalke B Clin Sci (Lond); 2012 Nov; 123(10):601-10. PubMed ID: 22690794 [TBL] [Abstract][Full Text] [Related]
5. Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. Ellis KL; Newton-Cheh C; Wang TJ; Frampton CM; Doughty RN; Whalley GA; Ellis CJ; Skelton L; Davis N; Yandle TG; Troughton RW; Richards AM; Cameron VA J Mol Cell Cardiol; 2011 Apr; 50(4):695-701. PubMed ID: 21276798 [TBL] [Abstract][Full Text] [Related]
6. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function. Nishikimi T; Mori Y; Ishimura K; Tadokoro K; Yagi H; Yabe A; Horinaka S; Matsuoka H Am J Med; 2004 Apr; 116(8):517-23. PubMed ID: 15063812 [TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study. Cannone V; Huntley BK; Olson TM; Heublein DM; Scott CG; Bailey KR; Redfield MM; Rodeheffer RJ; Burnett JC Hypertension; 2013 Nov; 62(5):860-5. PubMed ID: 24041948 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease. Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236 [TBL] [Abstract][Full Text] [Related]
9. Association of 2238T>C polymorphism of the atrial natriuretic peptide gene with coronary artery disease in Afro-Caribbeans with type 2 diabetes. Larifla L; Maimaitiming S; Velayoudom-Cephise FL; Ferdinand S; Blanchet-Deverly A; Benabdallah S; Donnet JP; Atallah A; Roussel R; Foucan L Am J Hypertens; 2012 May; 25(5):524-7. PubMed ID: 22170009 [TBL] [Abstract][Full Text] [Related]
10. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Schnabel R; Rupprecht HJ; Lackner KJ; Lubos E; Bickel C; Meyer J; Münzel T; Cambien F; Tiret L; Blankenberg S; Eur Heart J; 2005 Feb; 26(3):241-9. PubMed ID: 15618051 [TBL] [Abstract][Full Text] [Related]
11. T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients. Rubattu S; De Giusti M; Farcomeni A; Abbolito S; Comito F; Cangianiello S; Greco ES; Dito E; Pagliaro B; Cotugno M; Stanzione R; Marchitti S; Bianchi F; Di Castro S; Battistoni A; Burocchi S; Caprinozzi M; Pierelli G; Sciarretta S; Volpe M J Cardiovasc Med (Hagerstown); 2016 Aug; 17(8):601-7. PubMed ID: 25252038 [TBL] [Abstract][Full Text] [Related]
12. Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease. Szczeklik W; Sanak M; Rostoff P; Piwowarska W; Jakiela B; Szczeklik A Thromb Haemost; 2008 Nov; 100(5):893-8. PubMed ID: 18989535 [TBL] [Abstract][Full Text] [Related]
13. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease. Hung MJ; Cherng WJ; Cheng CW; Li LF Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078 [TBL] [Abstract][Full Text] [Related]
14. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease. Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859 [TBL] [Abstract][Full Text] [Related]
15. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
16. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors. Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356 [TBL] [Abstract][Full Text] [Related]
17. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Schnabel R; Messow CM; Lubos E; Espinola-Klein C; Rupprecht HJ; Bickel C; Sinning C; Tzikas S; Keller T; Genth-Zotz S; Lackner KJ; Münzel TF; Blankenberg S Eur Heart J; 2008 Mar; 29(5):649-57. PubMed ID: 18263867 [TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
19. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization. Andreassi MG; Botto N; Laghi-Pasini F; Manfredi S; Ghelarducci B; Farneti A; Solinas M; Biagini A; Picano E Int J Cardiol; 2005 May; 101(2):191-5. PubMed ID: 15882662 [TBL] [Abstract][Full Text] [Related]
20. Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study. Galluzzo S; Patti G; Dicuonzo G; Di Sciascio G; Tonini G; Ferraro E; Spoto C; Campanale R; Zoccoli A; Angeletti S Hum Immunol; 2011 Aug; 72(8):636-40. PubMed ID: 21565239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]